Compound Detail
CHEMBL2374220
LEDIPASVIR 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1nc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5[nH]c([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)ccc2-3)c[nH]1)C(C)C
Basic Information
| ChEMBL ID | CHEMBL2374220 |
| Name | LEDIPASVIR |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | VRTWBAAJJOHBQU-KMWAZVGDSA-N |
| Therapeutic | ✓ Yes |
2
Targets
36
Activities
2
Assay Types
30
PK Parameters
20
Publications
4
Known Names
6
Indications
1
Mechanisms
Molecular Properties
889.0
MW (Da)
8.61
ALogP
8
HBA
4
HBD
174.6
PSA (Ų)
0.11
QED
2
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2014 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Nonstructural protein 5A inhibitor | INHIBITOR | Nonstructural protein 5A | ✓ | ✓ |
Indications
Hepatitis C Hepatitis C, Chronic Infections Severe Acute Respiratory Syndrome Hepatitis B, Chronic Lymphoma
Activity Summary
EC50 34 meas. best 10.57
IC50 2 meas. best 7.68
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Hepatitis C virus CHEMBL379 | EC50 | 10.57 | 10.202 | 0.0 | 5 |
| Nonstructural protein 5A CHEMBL3307224 | EC50 | 10.51 | 7.5923 | 0.0 | 26 |
| Nonstructural protein 5A CHEMBL3307224 | IC50 | 7.68 | 7.535 | 21.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 7697.14 | ng.hr.mL-1 | Homo sapiens |
| AUC | 6265.81 | ng.hr.mL-1 | Homo sapiens |
| AUC | 4710.92 | ng.hr.mL-1 | Homo sapiens |
| AUC | 3562.3 | ng.hr.mL-1 | Homo sapiens |
| AUC | 2415.47 | ng.hr.mL-1 | Homo sapiens |
| AUC | 1987.85 | ng.hr.mL-1 | Homo sapiens |
| AUC | 617.87 | ng.hr.mL-1 | Homo sapiens |
| AUC | 496.07 | ng.hr.mL-1 | Homo sapiens |
| AUC | 217.81 | ng.hr.mL-1 | Homo sapiens |
| AUC | 124.46 | ng.hr.mL-1 | Homo sapiens |
| CL | 2.833 | mL.min-1.kg-1 | Macaca fascicularis |
| CL | 2.167 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 7.167 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 242.0 | nM | Homo sapiens |
| Cmax | 133.0 | nM | Homo sapiens |
| Cmax | 82.2 | nM | Homo sapiens |
| Cmax | 21.3 | nM | Homo sapiens |
| Cmax | 6.75 | nM | Homo sapiens |
| F | 53.0 | % | Canis lupus familiaris |
| F | 41.1 | % | Macaca fascicularis |
| F | 32.5 | % | Rattus norvegicus |
| F | 76.0 | % | Homo sapiens |
| MRT | 12.9 | hr | Macaca fascicularis |
| MRT | 9.2 | hr | Canis lupus familiaris |
| MRT | 6.19 | hr | Rattus norvegicus |
| T1/2 | 39.5 | hr | Homo sapiens |
| T1/2 | 44.2 | hr | Homo sapiens |
| T1/2 | 37.2 | hr | Homo sapiens |
| T1/2 | 42.4 | hr | Homo sapiens |
| T1/2 | 45.2 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine